髓样细胞触发性受体-1基础研究与临床应用 |
| |
引用本文: | 陈筱鸣,;张倩,;李晶华,;邵中军.髓样细胞触发性受体-1基础研究与临床应用[J].国外医学:分子生物学分册,2009(1):68-73. |
| |
作者姓名: | 陈筱鸣 ;张倩 ;李晶华 ;邵中军 |
| |
作者单位: | [1]第四军医大学流行病学教研室,西安市710032; [2]第四军医大学西京医院中医科,西安市710032 |
| |
摘 要: | 髓样细胞触发性受体-1(triggering receptor expressed on myeloid cells-1,TREM-1)是表达于中性粒细胞、单核细胞与巨噬细胞表面的免疫球蛋白家族胞膜受体。有研究显示,TREM-1能够放大模式识别受体介导的炎性反应,在全身炎性反应综合征(SIRS)中发挥重要作用。TREM.1在慢性炎性活动期、恶性肿瘤等病理过程中也有不同程度上凋。以TREM-1为靶点的靶向药物有望对上述疾病治疗产生重大影响。同时,游离型TREM-1(soluble TREM-1,sTREM-1)可作为判断多种疾病预后的重要指标。
|
关 键 词: | 髓样细胞触发性受体-1 信号转导 脓毒症 |
Basic Research and Clinical Application of Triggering Receptor Expressed on Myeloid Cells-1 |
| |
Institution: | CHEN Xiaoming, ZHANG Qian, LI Jinghua , SHAO Zhongjun(1.Department of Epidemiology , Fourth Military Medical University, Xi'an, 710032, China; 2.Division of Traditional Chinese Medicine, Xijing Hospital, Fourth Military Medical University, Xi' an, 710032, China) |
| |
Abstract: | Triggering receptor expressed on myeloid cells-1 ( TREM-1) is an immunoreceptor expressed on neutrophils, macrophage and monocytes. Previous studies have reported that TREM-1 amplifies inflammatory reaction mediated by pathogen recognizing receptor, playing an important role in the process of severe inflammatory reaction syndrome (SIRS) . Recently, it has been found that TREM-1 is increased to a certain extend in development of chronic diseases and malignant tumor. TREM-1 targeting drugs are anticipated to treat inflammatory diseases. Moreover, soluble TREM-1 may have prognostic value for various diseases. |
| |
Keywords: | TREM-1 signal transduction sepsis |
本文献已被 维普 等数据库收录! |
|